BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11545752)

  • 1. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
    Bray PF; Cannon CP; Goldschmidt-Clermont P; Moyé LA; Pfeffer MA; Sacks FM; Braunwald E
    Am J Cardiol; 2001 Aug; 88(4):347-52. PubMed ID: 11545752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
    Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes.
    O'Connor FF; Shields DC; Fitzgerald A; Cannon CP; Braunwald E; Fitzgerald DJ
    Blood; 2001 Dec; 98(12):3256-60. PubMed ID: 11719362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.
    Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE
    Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
    Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
    J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.
    Bojesen SE; Juul K; Schnohr P; Tybjaerg-Hansen A; Nordestgaard BG;
    J Am Coll Cardiol; 2003 Aug; 42(4):661-7. PubMed ID: 12932598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction.
    Arbustini E; Grasso M; Fasani R; Klersy C; Diegoli M; Porcu E; Banchieri N; Fortina P; Danesino C; Specchia G
    Br Heart J; 1995 Dec; 74(6):584-91. PubMed ID: 8541160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis.
    Ludwig E; Corneli PS; Anderson JL; Marshall HW; Lalouel JM; Ward RH
    Circulation; 1995 Apr; 91(8):2120-4. PubMed ID: 7697839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction.
    Yoshida M; Iwai N; Ohmichi N; Izumi M; Nakamura Y; Kinoshita M
    Int J Cardiol; 1999 Jul; 70(2):119-25. PubMed ID: 10454299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
    Anderson JL; King GJ; Bair TL; Elmer SP; Muhlestein JB; Habashi J; Carlquist JF
    J Am Coll Cardiol; 1999 Mar; 33(3):727-33. PubMed ID: 10080474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
    Maitland-van der Zee AH; Boerwinkle E; Arnett DK; Davis BR; Leiendecker-Foster C; Miller MB; Klungel OH; Ford CE; Eckfeldt JH
    Am Heart J; 2007 Jan; 153(1):54-8. PubMed ID: 17174637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of ACE I/D, AT1R A1166C, PAI-I 4G/5G and GPIIIa a1/a2 polymorphisms in myocardial infarction.
    Martínez-Quintana E; Chirino R; Nieto-Lago V; Pérez-Jiménez P; López-Ríos L; Rodríguez-González F
    Cardiol J; 2014; 21(3):229-37. PubMed ID: 23990179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-I-converting enzyme DD genotype is a risk factor of coronary artery disease.
    Sigusch HH; Vogt S; Gruber U; Reinhardt D; Lang K; Surber R; Farker K; Müller S; Hoffmann A
    Scand J Clin Lab Invest; 1997 Apr; 57(2):127-32. PubMed ID: 9200271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.
    Winkelmann BR; Nauck M; Klein B; Russ AP; Böhm BO; Siekmeier R; Ihnken K; Verho M; Gross W; März W
    Ann Intern Med; 1996 Jul; 125(1):19-25. PubMed ID: 8644984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
    Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients.
    Gardemann A; Weiss T; Schwartz O; Eberbach A; Katz N; Hehrlein FW; Tillmanns H; Waas W; Haberbosch W
    Circulation; 1995 Nov; 92(10):2796-9. PubMed ID: 7586243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ACE gene polymorphisms with coronary artery disease in a northern area of Japan.
    Takahashi K; Nakamura H; Kubota I; Takahashi N; Tomoike H
    Jpn Heart J; 1995 Sep; 36(5):557-64. PubMed ID: 8558760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients.
    Arca M; Pannitteri G; Campagna F; Candeloro A; Montali A; Cantini R; Seccareccia F; Campa PP; Marino B; Ricci G
    Eur J Clin Invest; 1998 Jun; 28(6):485-90. PubMed ID: 9693941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.